Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:1616-1623

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wildhirt, S. M.
Right arrow Articles by Reichart, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wildhirt, S. M.
Right arrow Articles by Reichart, B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Hazardous Substances DB
*NITRIC OXIDE

(Circulation. 1997;96:1616-1623.)
© 1997 American Heart Association, Inc.


Articles

Selective Modulation of Inducible Nitric Oxide Synthase Isozyme in Myocardial Infarction

Stephen M. Wildhirt, MD; Hiroshi Suzuki, MD; Damian Horstman; Susanne Weismüller, MD; Ryszard R. Dudek, MD, PhD; Kazuhide Akiyama, MD; ; Bruno Reichart, MD

From the Department of Cardiac Surgery, Ludwig-Maximilians University, Munich, Germany (S.M.W., S.W., W.P.W., B.R.), and the Department of Experimental Cardiology, Huntington Medical Research Institutes, Pasadena, Calif (H.S., D.H., R.R.D., K.A.).

Correspondence to Stephen M. Wildhirt, MD, Department of Cardiac Surgery, Ludwig-Maximilians University, Marchioninistr 15, 81377 Munich, Germany. E-mail wildhirt{at}hch.med.uni-muenchen.de

Background Inducible nitric oxide synthase (iNOS) is activated in cardiac disorders. We investigated the contribution of increased iNOS activity to the development of left ventricular dysfunction after myocardial infarction by selective inhibition of the isozyme.

Methods and Results Male New Zealand rabbits were subjected to myocardial infarction. Animals were treated with either saline, S-methylisothiourea sulfate (SMT) (a selective iNOS inhibitor), or N{omega}-nitro-L-arginine (L-NNA) (a nonselective NOS inhibitor). Inducible and constitutive NOS (cNOS) activity, plasma NOx, cGMP, hemodynamics, and myocardial blood flow were measured before and 5, 24, and 72 hours after coronary occlusion. Infarction 72 hours after occlusion resulted in increased myocardial iNOS activity, increased cardiac NOx production, and elevated cGMP levels. cNOS remained unchanged. Infarction increased left ventricular end-diastolic pressure (LVEDP) and decreased maximum +dP/dt and -dP/dt. L-NNA inhibited iNOS and cNOS activities and plasma NOx levels. L-NNA further increased LVEDP and reduced myocardial blood flow. Administration of SMT 72 hours after infarction significantly inhibited iNOS and cardiac NOx production but had no effects on cNOS. SMT improved left ventricular maximum +dP/dt and -dP/dt and decreased LVEDP. Myocardial blood flow in the remote myocardium increased.

Conclusions These findings suggest that induction of iNOS activity 72 hours after infarction exerts negative inotropic effects and contributes to the development of myocardial dysfunction; selective modulation of increased iNOS activity by SMT improves cardiac performance, enhances myocardial blood flow, and may be beneficial in the treatment of acute myocardial infarction.


Key Words: myocardial infarction • regional blood flow • hemodynamics • ischemia




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Fu, Z. Wang, W. L. Chen, P. K. Moore, and Y. Z. Zhu
Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1545 - H1552.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. Ndrepepa, A. Schomig, and A. Kastrati
Lack of Benefit From Nitric Oxide Synthase Inhibition in Patients With Cardiogenic Shock: Looking for the Reasons
JAMA, April 18, 2007; 297(15): 1711 - 1713.
[Full Text] [PDF]


Home page
CirculationHome page
H. Thai, L. Castellano, E. Juneman, H. Phan, R. Do, M. A. Gaballa, and S. Goldman
Pretreatment With Angiotensin Receptor Blockade Prevents Left Ventricular Dysfunction and Blunts Left Ventricular Remodeling Associated With Acute Myocardial Infarction
Circulation, October 31, 2006; 114(18): 1933 - 1939.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
D. K. Das and N. Maulik
Resveratrol in cardioprotection: a therapeutic promise of alternative medicine.
Mol. Interv., February 1, 2006; 6(1): 36 - 47.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
K. M. Azadzoi, T. A. Master, and M. B. Siroky
Effect of Chronic Ischemia on Constitutive and Inducible Nitric Oxide Synthase Expression in Erectile Tissue
J Androl, May 1, 2004; 25(3): 382 - 388.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. H. Han, E. Qamirani, A. G. Nelson, D. R. Hyduke, G. Chaudhuri, L. Kuo, and J. C. Liao
Regulation of nitric oxide consumption by hypoxic red blood cells
PNAS, October 14, 2003; 100(21): 12504 - 12509.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Qing, K. Schumacher, R. Heise, M. Woltje, J. F. Vazquez-Jimenez, T. Richter, M. Arranda-Carrero, J. Hess, G.o. von Bernuth, and M.-C. Seghaye
Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2266 - 2274.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-P. Wang, C. Sato, K. Mizoguchi, Y. Yamashita, M. Oe, and H. Maeta
Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase
Cardiovasc Res, October 1, 2002; 56(1): 33 - 42.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Saito, F. Hu, L. Tayara, L. Fahas, H. Shennib, and A. Giaid
Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H339 - H345.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Scherrer-Crosbie, R. Ullrich, K. D. Bloch, H. Nakajima, B. Nasseri, H. T. Aretz, M. L. Lindsey, A.-C. Vancon, P. L. Huang, R. T. Lee, et al.
Endothelial Nitric Oxide Synthase Limits Left Ventricular Remodeling After Myocardial Infarction in Mice
Circulation, September 11, 2001; 104(11): 1286 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Chen, D. Li, T. Saldeen, and J. L. Mehta
TGF-{beta}1 modulates NOS expression and phosphorylation of Akt/PKB in rat myocytes exposed to hypoxia-reoxygenation
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1035 - H1039.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Q. Feng, X. Lu, D. L. Jones, J. Shen, and J. M. O. Arnold
Increased Inducible Nitric Oxide Synthase Expression Contributes to Myocardial Dysfunction and Higher Mortality After Myocardial Infarction in Mice
Circulation, August 7, 2001; 104(6): 700 - 704.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Saito, M. P. Pelletier, H. Shennib, and A. Giaid
Nitric oxide system in needle-induced transmyocardial revascularization
Ann. Thorac. Surg., July 1, 2001; 72(1): 129 - 136.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. R. Ferreiro, A. C. P. Chagas, M. H. C. Carvalho, A. P. Dantas, M. B. Jatene, L. C. Bento de Souza, and P. Lemos da Luz
Influence of Hypoxia on Nitric Oxide Synthase Activity and Gene Expression in Children With Congenital Heart Disease : A Novel Pathophysiological Adaptive Mechanism
Circulation, May 8, 2001; 103(18): 2272 - 2276.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. B. Gustafsson and L. L. Brunton
beta -Adrenergic Stimulation of Rat Cardiac Fibroblasts Enhances Induction of Nitric-Oxide Synthase by Interleukin-1beta via Message Stabilization
Mol. Pharmacol., April 13, 2001; 58(6): 1470 - 1478.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Abe, M. Tokumura, T. Ito, T. Murai, A. Takashima, and N. Ibii
Involvement of iNOS in postischemic heart dysfunction of stroke-prone spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H668 - H673.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-P. Wang, H. Xu, K. Mizoguchi, M. Oe, and H. Maeta
Intestinal ischemia induces late preconditioning against myocardial infarction: a role for inducible nitric oxide synthase
Cardiovasc Res, February 1, 2001; 49(2): 391 - 398.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-T. Xuan, X.-L. Tang, Y. Qiu, S. Banerjee, H. Takano, H. Han, and R. Bolli
Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2360 - H2371.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Zhao, L. Xi, J. Chelliah, J. E. Levasseur, and R. C. Kukreja
Inducible Nitric Oxide Synthase Mediates Delayed Myocardial Protection Induced by Activation of Adenosine A1 Receptors : Evidence From Gene-Knockout Mice
Circulation, August 22, 2000; 102(8): 902 - 907.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Yang, B. Zingarelli, and C. Szabo
Crucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury
Circulation, March 7, 2000; 101(9): 1019 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Jung, L. A. Palmer, N. Zhou, and R. A. Johns
Hypoxic Regulation of Inducible Nitric Oxide Synthase via Hypoxia Inducible Factor-1 in Cardiac Myocytes
Circ. Res., February 18, 2000; 86(3): 319 - 325.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. Song, X. Lu, and Q. Feng
Tumor necrosis factor-{alpha} induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes
Cardiovasc Res, February 1, 2000; 45(3): 595 - 602.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Guo, W. K. Jones, Y.-T. Xuan, X.-L. Tang, W. Bao, W.-J. Wu, H. Han, V. E. Laubach, P. Ping, Z. Yang, et al.
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene
PNAS, September 28, 1999; 96(20): 11507 - 11512.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart
Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury
Cardiovasc Res, August 15, 1999; 43(3): 698 - 711.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. A. Gaballa, T. E. Raya, C. A. Hoover, and S. Goldman
Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction
Cardiovasc Res, June 1, 1999; 42(3): 627 - 635.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Li, K. Tomson, B. Yang, P. Mehta, B. P. Croker, and J. L. Mehta
Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: role of AT1 receptor activation
Cardiovasc Res, January 1, 1999; 41(1): 109 - 115.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Sam, D. B. Sawyer, Z. Xie, D. L.F. Chang, S. Ngoy, D. A. Brenner, D. A. Siwik, K. Singh, C. S. Apstein, and W. S. Colucci
Mice Lacking Inducible Nitric Oxide Synthase Have Improved Left Ventricular Contractile Function and Reduced Apoptotic Cell Death Late After Myocardial Infarction
Circ. Res., August 17, 2001; 89(4): 351 - 356.
[Abstract] [Full Text] [PDF]